期刊文献+

紫杉醇支架冠状动脉造影随访结果分析 被引量:2

Angiographic follow-up study of the effect after Taxus DES implantation in coronary artery disease patients
下载PDF
导出
摘要 目的 观察紫杉醇洗脱支架治疗冠心病的临床实际疗效。方法 297例患者接受紫杉醇洗脱支架治疗,均接受了临床随访,134例于支架置入术后5-15个月行冠状动脉造影随访。结果 冠状动脉造影随访时,晚期管腔丢失支架内显著高于支架近端边缘及支架远端边缘(分别为0.37、0.18和0.12mm),再狭窄率为10.4%,以支架内弥漫性狭窄为主,再血管化率为6.7%。1例患者于支架置入后4个月发生猝死,发生率为0.34%。1例于支架置入后5天发生支架内亚急性血栓形成,发生率0.34%。晚期血栓形成2例(术后12-24个月),主要心血管不良事件发生率1.35%。结论 紫杉醇药物洗脱支架对复杂冠脉病变有较好的疗效,能显著降低支架后再狭窄率及靶血管的再血管化率。 Objective To evaluate the angiographic effect in patients treated with Taxus DES implantation in clinical practice. Methods Two hundred and ninty-seven patients were treated with Taxus DES implantation and 134 patients underwent angiographic follow-up from 5 to 15 months. Results Angiographic follow-up the in-stent late loss was higher than pro-in-lesion and dis-in lesion late lumen loss (0. 37 vs O. 18 vs 0. 12mm,P〈0. 05). There were 14 case of restenosis in stentt (10. 4%) and 7 of 14cases were diffuse restenosis in stents (50%). Target lesion revascularization was performed in 6 cases (6. 7%). One patient died suddenly at 5th day after the procedure. The rate of sudden death was 0. 34%. One patient occurred subacute thrombosis in hospital (0. 34%) and two late thrombosis oceured in 12 and 24 months after operation (0. 68%). The rate of the incidence of major adverse cardiac events was 1.35%. Conclusion Unrestricted utilization of Taxus DES in daily practice is effective in reducing both restennosis and revascularization.
出处 《解放军医学杂志》 CAS CSCD 北大核心 2006年第7期708-710,共3页 Medical Journal of Chinese People's Liberation Army
关键词 支架 冠状动脉疾病 放射学 介入性 stents coronary disease radiology, interventional
  • 相关文献

参考文献7

  • 1Grube E,Silber S,Hauptmann KE et al.Taxus I:six and twelve month results from a randomized double blind trial on a slow release paclitaxel eluting stent for de Novo coronary lesions.Circulation,2003,107 (1):38
  • 2Colombo A,Drzewiecki J,Banning A et al.Randomized study to assess the effectiveness of slow and maderate release polymer based paclitaxel eluting stents for coronary artery lesions.Circulation,2003,108(7):788
  • 3Tanabe K,Serruys PW,Grube E et al.TaxusⅢ Trial:in stent restenosis treated with stent based belivery of paclitaxel incorporated in a slow release polymer formulation.Circulation,2003,107 (4):559
  • 4Schiff PB,Horwitz SB.Taxol stabilizes microtubules in mouse fibroblast cells.PNAS,1980,77:1561
  • 5Patrick W,Muzaffer D,Kengo T et al.Vascular responses at proximal and distal edges of paclitaxel-eluting stents serial intravascular ultrasound analysis from the Taxus II trial.Circulation,2004,109:627
  • 6Gregg W,Stephen G,David A et al.One-year clinical results with the slow release,polymer-based,paclitaxel-eluting Taxus stent.The Taxus-IV Trial.Circulation,2004,109:1942
  • 7Stone GW,Ellis SG,Cox DA et al.A polymer-based paclitaxel-eluting stent in patients with coronary artery disease.N Engl J Med,2004,350:221

同被引文献29

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部